Federal contractor · public award history
LEIDOS BIOMEDICAL RESEARCH INC
Parent: LEIDOS HOLDINGS, INC. ZL41ERXMPAR3
- Awards we know about
- 40
- Typical size
- $7.57M
- Middle of their public awards
- Dollars on those awards
- $1.19B
Most of their awards we can see fall roughly between $1.97M and $26.95M.
From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.
Awarding agencies
- Department of Health and Human Services (40)
Industries & product codes
Award history
- Department of Health and Human Services$381.86M
NCI OPERATIONAL TASK ORDER, FY26-FY27
- Department of Health and Human Services$4.29M
FY25 TO-C REFURBISH ELEVATORS
- Department of Health and Human Services$30.86M
CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM
- Department of Health and Human Services$89.56M
ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW IN I AND II: I. A RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF INVESTIGATIONAL THERAPEUTICS FOR THE TREATMENT OF COVID-19 (2,000 SUBJECTS
- Department of Health and Human Services$163.47M
MD NET
- Department of Health and Human Services$5.58M
CHARACTERIZATION OF MPOX
- Department of Health and Human Services$11.11M
PREDICTIVE DRUG TESTING IN ORGANOID MODELS
- Department of Health and Human Services$4.69M
GS-524 PHASE 1 TRIAL
- Department of Health and Human Services$8.89M
THE NIAID DIR FY26-27 OPERATIONAL TASK ORDER
- Department of Health and Human Services$42.92M
NIAID VRC FY26-27 OPERATIONAL TASK ORDER
- Department of Health and Human Services$56.50M
DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS
- Department of Health and Human Services$18.55M
IGF::OT::IGF BLDG. 538- 1ST FLOOR REFURBISHMENT AND INFRASTRUCTURE
- Department of Health and Human Services$70.21M
NIAID DCR FY26-27 OPERATIONAL TASK ORDER
- Department of Health and Human Services$11.76M
FY23 FACILITIES TO-A
- Department of Health and Human Services$97.53M
DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEOUT AND PUBLICATION OF FINDINGS OF A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT AND PEDIATRIC PATIENTS WITH UNKNOWN FEBRILE ILLNESS FR
- Department of Health and Human Services$1.86M
FY25 TO-H W3F1 RENOVATIONS
- Department of Health and Human Services$5.87M
THE NIAID MISSION AND SCOPE INCLUDING RESEARCH AND DEVELOPMENT OF VACCINES AND THERAPEUTICS FOR THE PREVENTION AND TREATMENT OF DISEASES OF HUMAN CONCERN, INCLUDING MALARIA. THE VACCINE RESEARCH CENTER (VRC) HAS DEVELOPED TWO MONOCLONAL ANTIBODIES (M
- Department of Health and Human Services$6.26M
MEDICINAL CHEMISTRY SUPPORT TO NCATS APP MEDCHEM INITIATIVE
- Department of Health and Human Services$1.55M
MANUFACTURING OF TPM SUITABLE FOR HUMAN USE
- Department of Health and Human Services$4.67M
NEOANTIGEN VACCINE CLINICAL TRIALS
- Department of Health and Human Services$9.23M
IGF::OT::IGF ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODY (BNABS) DRUG SUBSTANCE (DS) CLINICAL TRIAL MATERIAL PRODUCTION AND RELEASE
- Department of Health and Human Services$2.05M
FY25 TO-B
- Department of Health and Human Services$24.10M
CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS
- Department of Health and Human Services$10.48M
PROTEOMIC AND ANTIBODY PRODUCTION AND CHARACTERIZATION
- Department of Health and Human Services$6.14M
NIAID-DMID-ANTIVIRAL PROGRAM FOR PANDEMICS EARLY PHASE CLINICAL TRIAL(S)
- Department of Health and Human Services$2.00M
CHARACTERIZATION OF NANOPARTICLES ENCAPSULATING OLIGONUCLEOTIDES FOR TARGETING ENDOCYTOSIS IN NOCICEPTORS FOR THE TREATMENT OF NEUROPATHIC PAIN
- Department of Health and Human Services$341,379
FY24 FACILITIES TO A - 126615 CONVERSION OF ANIMAL ROOM
- Department of Health and Human Services$1.05M
FY24 FACILITIES TO E - W2F2 CCR AQUATICS FACILITY EXPANSION AND OFFICES ROOMS
- Department of Health and Human Services$25.65M
IGF::OT::IGF BIOBANK
- Department of Health and Human Services$15.05M
COORDINATED FACILITIES REQUIREMENTS FOR FY25 - FACILITIES TO I
- Department of Health and Human Services$61,516
MANUFACTURING CGMP GRADE HYDROXYCOBALAMINE
- Department of Health and Human Services$19.76M
IGF::OT::IGF RETROSPECTIVE TUMOR CHARACTERIZATION ANALYSIS
- Department of Health and Human Services$98,473
STABILITY STUDY SUPPORT OF R-VK4-116
- Department of Health and Human Services$38.89M
ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2)
- Department of Health and Human Services$1.35M
CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NES-100 AS A NASAL SPRAY OF A NEW ANALGESIC
- Department of Health and Human Services$921,875
LEAD OPTIMIZATION OF A LONG NON-CODING RNA (LNCRNA) AS A POTENTIAL LIPID- AND GLUCOSE-LOWERING THERAPEUTIC
- Department of Health and Human Services$64.86M
ENABLING NCI CLINICAL & RESEARCH DATA SHARING
- Department of Health and Human Services$2.51M
DEVELOP, QUALIFY IMMUNOLOGICAL ASSAYS, AND PROVIDE CLINICAL SAMPLE TESTING FOR AAV-BASED GENE THERAPY CLINICAL CANDIDATES
- Department of Health and Human Services$219,752
EVALUATION OF IVO COMPOUNDS IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS MODEL
- Department of Health and Human Services$794,843
PRODUCING USHER III RETINAL ORGANOIDS FROM PATIENT CELLS TO MEASURE THE EFFECT OF DRUG CANDIDATE
Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.